Trial Profile
Impact of Infectious Complications During Azacitidine Treatment in Patients with Myelodysplastic Syndromes: A Retrospective Study
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 22 Aug 2017
Price :
$35
*
At a glance
- Drugs Azacitidine (Primary)
- Indications Myelodysplastic syndromes
- Focus Therapeutic Use
- 22 Aug 2017 New trial record
- 01 Jul 2017 Results published in the Annals of Hematology